Drug Shortage Report for APO-SERTRALINE
| Report ID | 3186 |
| Drug Identification Number | 02238282 |
| Brand name | APO-SERTRALINE |
| Common or Proper name | SERTRALINE |
| Company Name | APOTEX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | SERTRALINE |
| Strength(s) | 100MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 250 BTL |
| ATC code | N06AB |
| ATC description | ANTIDEPRESSANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2017-03-31 |
| Actual start date | 2017-03-27 |
| Estimated end date | 2017-05-02 |
| Actual end date | 2017-04-28 |
| Shortage status | Resolved |
| Updated date | 2017-05-01 |
| Company comments | APO-SERTRALINE 100 MG CAP 100 BTL is available |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
| Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2017-03-17 | English | Compare |
| v2 | 2017-03-17 | French | Compare |
| v3 | 2017-03-27 | English | Compare |
| v4 | 2017-03-27 | French | Compare |
| v5 | 2017-03-28 | English | Compare |
| v6 | 2017-04-24 | English | Compare |
| v7 | 2017-04-24 | French | Compare |
| v8 | 2017-05-01 | English | Compare |
| v9 | 2017-05-01 | French | Compare |
Showing 1 to 9 of 9